Andreas Wicki - Profile and Investment Details

Investor Profile

Andreas Wicki is a Venture Capital based in Zug, Canton of Zug, Switzerland with a diverse investment portfolio that includes companies such as Y-mAbs Therapeutics, BioShin, Visen PharmaceuticalsIO Biotech, Karius, Genalyte, Nabriva Therapeutics, Jianke, Complexa, ARMO BioSciences, connectRN, Shape Memory Medical, Aptinyx, Homology Medicines, Viela Bio, Mineralys Therapeutics, SpringWorks Therapeutics, Turning Point Therapeutics, Nuance Biotech, Amphora Medical, Longboard Pharmaceuticals, Swixx Biopharma, Werewolf Therapeutics, CardiaLen, Sublimity Therapeutics, Harmony Biosciences, Forbius, MicroOptx, 4TEEN4 Pharmaceuticals, EGenesis, SAI Life Sciences, ALX Oncology, Everest Medicines, AnaptysBio, Advanced Accelerator Applications, Neuron23, Iconic Therapeutics, NiKang Therapeutics, Corvidia, Farmalisto, Seer, Neurelis, Celladon, Vascular Dynamics, Kolltan Pharmaceuticals, AMICUS SA, Monte Rosa Therapeutics, Galera Therapeutics, Dren Bio, BioAtla, Autonomic Technologies, Ambrx, Fore Biotherapeutics, True North Therapeutics, Instil Bio, Galecto, Arrakis Therapeutics, Vitaeris, BaseHealth, ITeos Therapeutics, Everlife, Adrenomed, C4 Therapeutics, ObsEva, Valo Health, Arcutis Biotherapeutics, Pyxis Oncology, Connect Biopharmaceuticals, POLYNEURON, 1mg, Fog Pharmaceuticals, . Over time, Andreas Wicki has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Andreas Wicki is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Hospitals, Genetics, Women Founded, Life Science, Biotechnology, Genomics, Medical, Real Estate, Therapeutics, Pharmaceuticals may find it worthwhile to explore potential connections with Andreas Wicki, as their portfolio suggests a familiarity and interest in this area.

Understanding Andreas Wicki’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.